OR WAIT null SECS
June 13, 2022
REGENXBIO has opened a new in-house facility at its headquarters in Rockville, Md., that will be used to manufacture AAV gene therapies at commercial scale.
June 10, 2022
Astellas Pharma has opened its new gene therapy manufacturing facility in Sanford, NC, which will support clinical- and commercial-scale manufacturing of AAV vectors for gene therapies.
June 08, 2022
Eli Lilly and Company plans to build two new manufacturing sites at Indiana's LEAP Lebanon Innovation and Research District in Boone County.
May 26, 2022
AGC Biologics is investing in viral vector suspension technology at its new Longmont, Colo., facility.
May 13, 2022
Through a collaboration, Avantor and Cytovance Biologics will accelerate plasmid optimization and sourcing services for viral vectors and mRNA-based vaccines and therapeutics.
May 02, 2022
Complex hurdles complicate the development of emerging therapies.
Plant-based manufacturing technology gains mainstream edge in biopharmaceutical production.
April 13, 2022
VectorBuilder will expand with the construction of new $500 million Gene Delivery Research and Manufacturing Campus in Guangzhou, China.
March 10, 2022
UCB has announced it will build a new innovative gene therapy facility in Belgium.
March 01, 2022
CGTs offer hope for the future of treatments, but the costly manufacturing, slow turnaround time, and need for supplies hinder progress.